Cronos Group Inc (CRON)
$7.30
0.48 (7.04%)
CRON Stock Quote Delayed 15 Minutes
Previous Close
$7.30
Market Cap
1.29B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
7.50M
Day's Range
6.81 - 7.33
52-Week Range
6.04 - 25.10
Dividend & Yield
N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
With Altria in the Driver’s Seat, It’s Tough to Play Cronos Stock
This makes it tough for average investors to win with Cronos stock. On the other hand, high-short interest may mean its too late to go short CRON. The company's shares could rally in a short squeeze scenario. So what's your play with Cronos stock? Avoid!
Investors Should Use Other Metrics to Evaluate Cronos Group Stock
Some believe that Cronos stock overvalued. But if you consider cash on the balance sheet, CRON stock is more than reasonable.
Cronos Stock Will Eventually Rebound, but Not Anytime Soon
Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now.
Don’t Count on Altria to Keep the Price of Cronos Stock Propped Up
Cronos stock is severely overvalued and is likely to fall further. Cronos is more expensive than any other Canadian cannabis stock, even despite the recent Altria investment
Friday’s Vital Data: Intel, Tesla and Cronos Group
Options trading was hot in Intel, Tesla and Cronos Group stocks on Thursday. Here’s what the data suggests moving forward.
Investors Should Jump Into Cronos Group Stock’s Mystery Moves
CRON stock is not for the faint of heart. Do you think you have what it takes to profit from this pot powerhouse?
Friday’s Vital Data: Cronos Group, Netflix and Disney
Options trading was buzzing in Cronos Group, Netflix and Disney on Thursday. Here are the metrics that matter moving forward.
Cronos Australia Offers Little Help to Cronos Group Stock
Cronos Australia could help lend some credibility to Cronos Group, but it appears too small to significantly affect CRON stock.
4 Reasons to Buy Cronos Stock On the Vaping Dip
CRON stock is down more than 50% on concerns about slowing cannabis growth in Canada and vaping-related health concerns. However, there are plenty of reasons for long-term investors to buy the dip.
Altria’s Juul Labs Investment Not Looking So Hot
While I believe that regulators will ultimately get this entire health scare sorted and both Juul and Cronos will go back to running their businesses, I can’t help but think how relieved Altria’s management must be that they made the $1.8 billion investment in Cronos in exchange for 45% of its stock.
Avoid Cronos Group Stock Even After Yesterday’s Cannabis Carnage
Health impact of vaping makes CRON stock a concern from a regulatory and growth perspective. Keep it on the investment radar, but shares aren't likely to trend higher anytime soon.
Stock Market Today: Trade Talks Start; Cannabis Stocks Burned
Cannabis stocks were torched Thursday, while trade talks continue. Here's what happened in the stock market today.
5 Top Stock Trades for Friday: FCX, COUP, Cannabis
Freeport-McMoRan, Coupa, Hexo, Cronos Group and Aphria were our top stock trades to watch on Thursday, as trade talks continue.
CRON Stock Still a Falling Knife Without a Catalyst
CRON stock continues to plunge, and with near-term profits unlikely and valuation still high, the declines may well continue.
Here’s How the Mandela Effect Has Hurt Cronos Group Stock
Hysteria over the vaping crisis has hurt CRON stock. But investors should have patience until all the facts are straightened out.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
